Agriculture Reference
In-Depth Information
Chapter 15
Aragona, M., Onesti, E., Tomassini, V., Conte, A., Gupta, S., Gilio, F.,
et al
. (2008)
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a
double-blind, placebo controlled, crossover study.
Clinical Neuropharmacology
23 October
(electronic publication).
Aviello, G., Romano, B. and Izzo, A.A. (2008) Cannabinoids and gastrointestinal motility: animal and human
studies.
European Review for Medical and Pharmacological Sciences
12(Supp. 1), 81-93.
BMA [British Medical Association] (1997)
Therapeutic Uses of Cannabis
, Harwood Academic Publishers,
142 pp.
Brady, C.M., DasGupta, R., Dalton, C., Wiseman, O.J., Berkley, K.J. and Fowler, C.J. (2004) An open-label
pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.
Multiple
Sclerosis
10(4), 425-433.
Caballero, F. and Bisiou, Y. (2000)
Droit de la drogue
(2nd edition). Dalloz, Paris, 827 pp.
Campbell, F.A., Tramer, M.R., Carroll, D., Reynolds, D.J., Moore, R.A. and McQuay, H.J. (2001) Are can-
nabinoids an effective and safe treatment option in the management of pain? A qualitative systematic
review.
British Medical Journal
323(7303), 13-16.
Carroll, C.B., Bain, P.G., Teare, L., Liu, X., Joint, C., Wroath, C.,
et al
. (2004) Cannabis for dyski-
nesia in Parkinson disease: a randomised double-blind crossover study.
Neurology
63(7),
1245-1250.
Clapper, J.R., Mangieri, R.A. and Piomelli, D. (2009) The endocannabinoid system as a target for the treat-
ment of cannabis dependence.
Neuropharmacology
56(Supp. 1), 235-243.
Correa, F., Mestre, L., Molina-Holgado, E., Arévalo-Martin, A., Docagne, F., Romero, E.,
et al
. (2005) The
role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.
Mini Reviews in Medicinal Chemistry
5(7), 671-675.
Croxford, J.L. and Miller, S.D. (2004) Towards cannabis and cannabinoid treatment of multiple sclerosis.
Drugs Today
40(8), 663-676.
Davis, M.P. (2008) Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting
and pain.
Expert Opinion on Investigational Drugs
17(1), 85-95.
Degenhardt, L. and Hall, W.D. (2008) The adverse effects of cannabinoids: implications for use of medical
marijuana.
CMAJ
178(13), 1685-1686.
De Jong, B.C., Prentiss, D., McFarland, W., Machekano, R. and Israelski, D.M. (2005) Marijuana use and its
association with adherence to antiretroviral therapy among HIV-infected persons with moderate to
severe nausea.
Journal of Acquired Immune Deficiency Syndrome
38(1), 43-46.
Elkhasef, A., Vocci, F., Huestis, M., Haney, M., Budney, A., Gruber, A.,
et al
. (2008) Marijuana neurobiology
and treatment.
Substance Abuse
29(3), 17-29.
EMCDDA [European Monitoring Centre for Drugs and Drug Addiction] (2008)
A Cannabis Reader: Global
Issues and Local Experiences
. Monographie No 8 (2 volumes), 746 pp
(www.emcdda.europa.eu/
Engels, F.K., de Jong, F.A., Mathijssen, R.H., Erkens, J.A., Herings, R.M. and Verweij, J. (2007) Medicinal
cannabis in oncology.
European Journal of Cancer
43(18), 2638-2644.
Grinspoon, L. and Bakalar, J. (1993)
Marihuana, The Forbidden Medicine
. Yale University Press, New
Haven, Connecticut.
Gross, D.W., Hamm, J., Ashworth, N.L. and Quigley, D. (2004) Marijuana use and epilepsy: prevalence in
patients of a tertiary care epilepsy center.
Neurology
62(11), 1924-1925.
Hanus, L.O. (2009) Pharmacological and therapeutics secrets of plant and brain (endo) cannabinoids.
Medicinal Research Reviews
29(2), 213-271.
Hazekamp, A., Ruhaak, P., Zuurman, L., van Gerven, J. and Verpoorte, R. (2006) Evaluation of a vaporizing
device (Volcano
™
) for the pulmonary administration of tetrahydrocannabinol.
Journal of Pharmacological
Sciences
95(6), 1308-1317.
Hosking, R.D. and Zajicek, J.P. (2008) Therapeutic potential of cannabis in pain medicine.
British Journal
of Anaethesia
101, 59-68.
